9.1833
전일 마감가:
$9.00
열려 있는:
$9
하루 거래량:
2,788
Relative Volume:
0.62
시가총액:
$44.42M
수익:
$2.61M
순이익/손실:
$1.69M
주가수익비율:
30.58
EPS:
0.3003
순현금흐름:
-
1주 성능:
-1.57%
1개월 성능:
-1.15%
6개월 성능:
+11.74%
1년 성능:
-3.13%
Daxor Corporation Stock (DXR) Company Profile
명칭
Daxor Corporation
전화
212-330-8500
주소
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
DXR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
DXR
Daxor Corporation
|
9.1833 | 46.30M | 2.61M | 1.69M | 0 | 0.3003 |
![]()
ISRG
Intuitive Surgical Inc
|
516.12 | 185.10B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
175.33 | 50.76B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
87.16 | 43.19B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
261.07 | 37.26B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
210.08 | 16.13B | 2.90B | 467.20M | 306.90M | 6.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2019-05-16 | 개시 | Ascendiant Capital Markets | Buy |
Daxor Corporation 주식(DXR)의 최신 뉴스
Daxor Corporation Stock Analysis and ForecastAccelerated earnings growth - Autocar Professional
What analysts say about Daxor Corporation stockExplosive trading opportunities - Autocar Professional
Navigating Taxation Rules for Stock Investment in India Strategic Stock PicksPowerful growth strategies - PrintWeekIndia
What analysts say about Stock Yards Bancorp Inc. stockAccelerated capital growth - PrintWeekIndia
(DXR) Proactive Strategies - news.stocktradersdaily.com
Is Daxor Corporation a good long term investmentSuperior capital gains - jammulinksnews.com
What analysts say about Peloton Interactive Inc. stockHigh-velocity gains - jammulinksnews.com
Akero Therapeutics Inc. Stock Analysis and ForecastFree Stock Market Trend Analysis - jammulinksnews.com
What drives Daxor Corporation stock priceUnrivaled growth potential - Autocar Professional
What analysts say about TIPT stockSuperior returns - jammulinksnews.com
What drives Bellevue Life Sciences Acquisition Corp. Equity Warrant stock priceHigh-impact stock picks - jammulinksnews.com
What analysts say about Harvard Bioscience Inc. stockHigh-performance investment picks - jammulinksnews.com
What drives Entergy Corporation stock priceExceptional market positioning - jammulinksnews.com
How high can Daxor Corporation stock price go in 2025Fast Growing Stocks - Newser
How Daxor Corporation stock performs during market volatilityCapital Safe Smart Trades - Newser
Why Daxor Corporation stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser
Daxor Corporation (NASDAQ:DXR) Q4 2024 Earnings Call Transcript - MSN
What makes Daxor Corporation stock price move sharplyLow Risk Consistent Winners - Newser
How to Take Advantage of moves in (DXR) - news.stocktradersdaily.com
Daxor elects board members and ratifies auditor at annual meeting - Investing.com
Daxor Approves Accounting Firm at Annual Meeting - TipRanks
Critical Review: Daxor (NASDAQ:DXR) versus Option Care Health (NASDAQ:OPCH) - Defense World
Daxor Corporation Expands Blood Volume Analysis Technology to Major New Jersey Hospitals - The Globe and Mail
(DXR) Technical Pivots with Risk Controls - news.stocktradersdaily.com
(DXR) Investment Analysis - news.stocktradersdaily.com
Daxor announces new findings from Duke University on BVA - TipRanks
Daxor (DXR) Highlights Key Heart Failure Study Results | DXR Sto - GuruFocus
Daxor Announces Duke University Study on Blood Volume - GlobeNewswire
Duke Research Reveals 40% of Heart Failure Patients Misdiagnosed with Anemia, Study Shows - Stock Titan
Daxor (DXR) Expands Diagnostic Solutions Across U.S. Healthcare Systems | DXR Stock News - GuruFocus
Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems - GlobeNewswire
Daxor announces opening of new BVA program at Florida center - TipRanks
Daxor (DXR) Launches Advanced BVA Program in Tampa Bay Healthcare Center | DXR Stock News - GuruFocus
Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology - GlobeNewswire
Renaissance Technologies LLC Has $214,000 Stock Holdings in Daxor Co. (NASDAQ:DXR) - Defense World
Daxor announces expansion of BVA capabilities in three new hospitals - TipRanks
Daxor (DXR) Expands Blood Volume Analysis with New Hospital Part - GuruFocus
Daxor (DXR) Expands Blood Volume Analysis with New Hospital Partnerships | DXR Stock News - GuruFocus
Three New Medical Centers Adopt Daxor's Blood Volume Diagnostic Signaling Growing Clinical Acceptance - GlobeNewswire
NeuroMetrix (NASDAQ:NURO) and Daxor (NASDAQ:DXR) Head-To-Head Comparison - Defense World
Daxor Corporation (DXR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):